Goodwin Biotechnology was awarded, “Best in Sector: Biopharmaceutical Contract Development & Manufacturing,” at Acquisition International magazine’s 2015 Sector Performance Awards.

These awards honor the companies and professionals who excel in their respective sectors, as well as providing specialized services for their clients. Based near Fort Lauderdale in FL, Goodwin Biotechnology is a fully integrated cGMP contract development and manufacturing organization (CDMO) of biopharmaceuticals utilizing mammalian cell culture expression systems and bioconjugation technologies for the production of monoclonal antibodies, recombinant proteins, vaccines, antibody drug conjugates (ADCs) and other bioconjugates for clients. They received this award for their excellence and innovation in the field of biopharmaceutical contract development and manufacturing.

“We at Goodwin Biotechnology are excited to be recognized for this distinguished award by Acquisition International,” said Soo Young Lee, chief operating officer, Goodwin Biotechnology. “This award reflects the teamwork and commitment as well as the specialized skill sets of the staff at Goodwin Biotechnology who are laser focused on partnering with our clients to deliver high quality biopharmaceuticals that hold promises to positively impact patients and their families.”